Vaccine Development/Infectious Disease Studies
Vaccine Development/Infectious Challenge Studies Services
Pharmaron’s infectious disease specialists at our Phase l clinical research center in Maryland have completed over 50 vaccine studies. This includes viral/bacterial infection or challenge studies in campylobacter, cryptosporidium, malaria, cholera, influenza, CMV, streptococcus, staphylococcus, RSV, SARS-CoV-2 and norovirus.
- Experienced viral and bacterial challenge study site
- Isolation unit for participant and study separation
- Trial execution and study data analysis led by experienced board-certified infectious disease physicians
Site Safety and Proximity
- Site allows for isolation of vaccine and infectious disease studies to ensure subject safety and data integrity
- Close collaboration with local and nationally recognized academic and government clinical centers of excellence
Capabilities
